Biocept inc stock split
Jan 01, 2010 · Biocept Labs (NASDAQ: BIOC) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. BIOC Price Target and Analyst Ratings (Biocept) | MarketBeat Nov 07, 2019 · 1 Wall Street analysts have issued ratings and price targets for Biocept in the last 12 months. Their average twelve-month price target is $1.00, suggesting that the stock has a possible upside of 254.61%. The high price target for BIOC is $1.00 and the low price target for BIOC is $1.00. Biocept (BIOC) Stock: Soaring On Positive PR | CNA Finance
Mar 23, 2020 Real-time trade and investing ideas on Biocept BIOC from the largest community of traders and investors.
Biocept Stock Split History Biocept (BIOC) has 2 splits in our Biocept stock split history database. The first split for BIOC took place on September 29, 2016. This was a 1 for 3 reverse split, meaning for each 3 shares of BIOC owned pre-split, the shareholder now owned 1 share. Biocept (BIOC) Stock: Continues Soaring On BCBS News | CNA ... Jan 11, 2017 · Biocept Inc (NASDAQ: BIOC) Biocept is having an incredible day in the market today. This is following up on the large gains that we saw on the stock … BIOC: Message Board for Biocept, Inc. - InvestorVillage
Nov 07, 2019 · 1 Wall Street analysts have issued ratings and price targets for Biocept in the last 12 months. Their average twelve-month price target is $1.00, suggesting that the stock has a possible upside of 254.61%. The high price target for BIOC is $1.00 and the low price target for BIOC is $1.00.
BIOC Stock News - Fidelity Apr 01, 2020 · Shares of Biocept Inc. (BIOC) plummeted 42% on very heavy volume in morning trading Monday, after the provider of liquid cancer tests announced the pricing of stock offering at a deep discount.The company said it agreed on the issuance and sale of 23 million shares of common stock to several institutional investors, which would increase the shares outstanding by about 54%, according … Biocept, Inc. (BIOC) CEO Michael Nall on Q4 2019 Results ... Biocept, Inc. (NASDAQ:BIOC) Q4 2019 Results Earnings Conference Call March 25, 2020 4:30 PM ET Company Participants Jody Cain - LHA, IR Michael Nall - President & CEO Tim Kennedy - SVP, Operations Biocept Reports 2019 Fourth Quarter and Full Year ... 13 days ago · Biocept Reports 2019 Fourth Quarter and Full Year Financial Results - Fourth quarter revenues reached a record $1.8 million, up 108% over the fourth quarter of …
Mar 23, 2020 Real-time trade and investing ideas on Biocept BIOC from the largest community of traders and investors.
Jul 09, 2018 · BIOCEPT, INC. (NASDAQ:BIOC) Files An 8-K Material Modification to Rights of Security HoldersItem 3.03 Material Modification to Rights of Security Holders. The reverse stock split will … Biocept Stock Forecast: up to 0.271 USD! - BIOC Stock ... Biocept, Inc () Stock Market infoRecommendations: Buy or sell Biocept stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Biocept share forecasts, stock quote and buy / sell signals below.According to present data Biocept's BIOC shares and potentially its market environment have been in bearish cycle last 12 months (if exists). BIOC - Biocept Labs Summary, Stock Quote and News | Benzinga
View Biocept, Inc. BIOC investment & stock information. Get the latest Biocept, Inc. BIOC detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
Aug 12, 2019 Biocept conducted a 1-for-30 reverse stock split of its outstanding common stock in July 2018. The company had cash and cash equivalents of BIOC shares outstanding history table and chart, presented by 5 Years chart. BIOC Split History: Sep 29, 2016 - 1:3, Jul 10, 2018 - 1:30 About Biocept Inc. At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Biocept, Inc. If you are looking for stocks with good return, Mar 5, 2020 The reverse split follows a 1-for-10 split in March 2018 and four reverse splits in 2017 that increased the stock price by a multiple of 18,000 that Shares of Biocept Inc. plummeted 42% on very heavy volume in morning trading Monday, after the provider of liquid cancer tests announced the pricing of stock
Moving on, BIOC stock price is currently trading at 0X forward 12-month Consensus EPS estimates, and its P/E ratio is 0 while for the average stock in the same group, the multiple is 48.2. Biocept, Inc. current P/B ratio of 1.8 means it is trading at a discount against its industry’s 5. Biocept Inc. (Nasdaq: BIOC) :: LD Micro The Company completed a 1-for-30 reverse stock split of its common stock in July 2018. Biocept reported cash and cash equivalents as of September 30, 2019 of $6.5 million, compared with $3.4 million as of December 31, 2018. The increase was due to $17.0 million in net proceeds from equity capital raises conducted in the first quarter of 2019 Biocept Stock Split History Biocept (BIOC) has 2 splits in our Biocept stock split history database. The first split for BIOC took place on September 29, 2016. This was a 1 for 3 reverse split, meaning for each 3 shares of BIOC owned pre-split, the shareholder now owned 1 share. Biocept (BIOC) Stock: Continues Soaring On BCBS News | CNA ...